guest ::
| Home > Publications database > Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity. > print |
| Home > Publications database > Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity. > print |
| 001 | 126647 | ||
| 005 | 20240228140838.0 | ||
| 024 | 7 | _ | |a 10.1007/s00066-014-0740-z |2 doi |
| 024 | 7 | _ | |a pmid:25156510 |2 pmid |
| 024 | 7 | _ | |a 0039-2073 |2 ISSN |
| 024 | 7 | _ | |a 0179-7158 |2 ISSN |
| 024 | 7 | _ | |a 1439-099X |2 ISSN |
| 037 | _ | _ | |a DKFZ-2017-02675 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Häfner, Matthias Felix |b 0 |
| 245 | _ | _ | |a Postoperative radiotherapy of patients with thymic epithelial tumors (TET): a retrospective analysis of outcome and toxicity. |
| 260 | _ | _ | |a Heidelberg |c 2015 |b Springer51814 |
| 264 | _ | 1 | |3 online |2 Crossref |b Springer Science and Business Media LLC |c 2014-08-26 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-02-01 |
| 264 | _ | 1 | |3 print |2 Crossref |b Springer Science and Business Media LLC |c 2015-02-01 |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1522152040_18537 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The purpose of this study was to evaluate postoperative radiotherapy regarding outcome and toxicity in patients with thymic epithelial tumors (TET) after surgery.We retrospectively analyzed medical records of 41 patients with TET treated with postoperative radiotherapy at our institution between 1995 and 2012. The impact of prognostic factors (e.g., Masaoka stage, histological subtype) was investigated and radiation-related toxicity was assessed.Median age was 59.8 years and median follow-up was 61 months. In 24.4 %, TETs were associated with paraneoplastic syndromes. The 5-year overall survival (OS) was 89.5 % and the 5-year disease-free survival (DFS) was 88.9 %. Masaoka stage had a significant impact on OS (p = 0.007). Locally limited stages I + II had a 5-year OS of 100 % compared to 80 % for stage III and 66.7 % for stage IV. The 5-year DFS was excellent with 100 % for both WHO groups A/AB/B1 and B2, respectively, and significantly (p = 0.005) differed from B3/C-staged patients with a 5-year DFS of 63.6 %. Resection status, paraneoplastic association, radiation dose, or tumor size did not influence survival. There were no high-grade acute or late side effects caused by radiotherapy.Masaoka stage has a significant impact on OS as WHO type has on DFS in patients with TETs after surgery and adjuvant irradiation. Postoperative radiotherapy with doses around 50 Gy is safe and not likely to cause high-grade toxicity. Further prospective trials are necessary to separate patient subgroups that benefit from radiotherapy from those that do not. |
| 536 | _ | _ | |a 315 - Imaging and radiooncology (POF3-315) |0 G:(DE-HGF)POF3-315 |c POF3-315 |f POF III |x 0 |
| 542 | _ | _ | |i 2014-08-26 |2 Crossref |u http://www.springer.com/tdm |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 700 | 1 | _ | |a Roeder, Falk |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Sterzing, Florian |0 P:(DE-He78)75d45845a04db67c5a88db1086046ef1 |b 2 |u dkfz |
| 700 | 1 | _ | |a Krug, David |b 3 |
| 700 | 1 | _ | |a Koerber, Stefan A |b 4 |
| 700 | 1 | _ | |a Kappes, Jutta |b 5 |
| 700 | 1 | _ | |a Hoffmann, Hans |b 6 |
| 700 | 1 | _ | |a Slynko, Alla |0 P:(DE-He78)4169c43af2de6fae487c89fc2e7cfaa8 |b 7 |u dkfz |
| 700 | 1 | _ | |a Debus, Jürgen |0 P:(DE-He78)8714da4e45acfa36ce87c291443a9218 |b 8 |u dkfz |
| 700 | 1 | _ | |a Bischof, Marc |b 9 |
| 773 | 1 | 8 | |a 10.1007/s00066-014-0740-z |b Springer Science and Business Media LLC |d 2014-08-26 |n 2 |p 133-140 |3 journal-article |2 Crossref |t Strahlentherapie und Onkologie |v 191 |y 2014 |x 0179-7158 |
| 773 | _ | _ | |a 10.1007/s00066-014-0740-z |g Vol. 191, no. 2, p. 133 - 140 |0 PERI:(DE-600)2003907-4 |n 2 |p 133-140 |t Strahlentherapie und Onkologie |v 191 |y 2014 |x 0179-7158 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:126647 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 1 |6 P:(DE-HGF)0 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 2 |6 P:(DE-He78)75d45845a04db67c5a88db1086046ef1 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 7 |6 P:(DE-He78)4169c43af2de6fae487c89fc2e7cfaa8 |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 8 |6 P:(DE-He78)8714da4e45acfa36ce87c291443a9218 |
| 913 | 1 | _ | |a DE-HGF |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-315 |2 G:(DE-HGF)POF3-300 |v Imaging and radiooncology |x 0 |4 G:(DE-HGF)POF |3 G:(DE-HGF)POF3 |b Gesundheit |
| 914 | 1 | _ | |y 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b STRAHLENTHER ONKOL : 2015 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0310 |2 StatID |b NCBI Molecular Biology Database |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Thomson Reuters Master Journal List |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0110 |2 StatID |b Science Citation Index |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0111 |2 StatID |b Science Citation Index Expanded |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |
| 915 | _ | _ | |a IF < 5 |0 StatID:(DE-HGF)9900 |2 StatID |
| 920 | 1 | _ | |0 I:(DE-He78)E055-20160331 |k E055 |l Molekulare Radioonkologie |x 0 |
| 920 | 1 | _ | |0 I:(DE-He78)E050-20160331 |k E050 |l KKE Strahlentherapie |x 1 |
| 920 | 1 | _ | |0 I:(DE-He78)C060-20160331 |k C060 |l Biostatistik |x 2 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)E055-20160331 |
| 980 | _ | _ | |a I:(DE-He78)E050-20160331 |
| 980 | _ | _ | |a I:(DE-He78)C060-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| 999 | C | 5 | |a 10.1002/ijc.11099 |9 -- missing cx lookup -- |1 EA Engels |p 546 - |2 Crossref |u Engels EA, Pfeiffer RM (2003) Malignant thymoma in the United States: demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer 105:546–551 |t Int J Cancer |v 105 |y 2003 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2009.09.066 |9 -- missing cx lookup -- |1 YD Chen |p 1400 - |2 Crossref |u Chen YD, Feng QF, Lu HZ et al (2010) Role of adjuvant radiotherapy for stage II thymoma after complete tumor resection. Int J Radiat Oncol Biol Phys 78:1400–1406 |t Int J Radiat Oncol Biol Phys |v 78 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2004.05.013 |9 -- missing cx lookup -- |1 G Zhu |p 1113 - |2 Crossref |u Zhu G, He S, Fu X et al (2004) Radiotherapy and prognostic factors for thymoma: a retrospective study of 175 patients. Int J Radiat Oncol Biol Phys 60:1113–1119 |t Int J Radiat Oncol Biol Phys |v 60 |y 2004 |
| 999 | C | 5 | |a 10.1016/S0003-4975(03)00555-1 |9 -- missing cx lookup -- |1 K Kondo |p 878 - |2 Crossref |u Kondo K, Monden Y (2003) Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan. Ann Thorac Surg 76:878–884 (discussion 884–875) |t Ann Thorac Surg |v 76 |y 2003 |
| 999 | C | 5 | |a 10.1200/JCO.1988.6.11.1722 |9 -- missing cx lookup -- |1 WJ Curran Jr |p 1722 - |2 Crossref |u Curran WJ Jr, Kornstein MJ, Brooks JJ et al (1988) Invasive thymoma: the role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol 6:1722–1727 |t J Clin Oncol |v 6 |y 1988 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2009.02.016 |9 -- missing cx lookup -- |1 JA Forquer |p 440 - |2 Crossref |u Forquer JA, Rong N, Fakiris AJ et al (2010) Postoperative radiotherapy after surgical resection of thymoma: differing roles in localized and regional disease. Int J Radiat Oncol Biol Phys 76:440–445 |t Int J Radiat Oncol Biol Phys |v 76 |y 2010 |
| 999 | C | 5 | |a 10.1097/JTO.0b013e3181f20ec4 |9 -- missing cx lookup -- |1 CD Fuller |p 327 - |2 Crossref |u Fuller CD, Ramahi EH, Aherne N et al (2010) Radiotherapy for thymic neoplasms. J Thorac Oncol 5:S 327–335 |t J Thorac Oncol |v 5 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.athoracsur.2008.11.022 |9 -- missing cx lookup -- |1 RJ Korst |p 1641 - |2 Crossref |u Korst RJ, Kansler AL, Christos PJ et al (2009) Adjuvant radiotherapy for thymic epithelial tumors: a systematic review and meta-analysis. Ann Thorac Surg 87:1641–1647 |t Ann Thorac Surg |v 87 |y 2009 |
| 999 | C | 5 | |a 10.1002/1097-0142(19811201)48:11<2485::AID-CNCR2820481123>3.0.CO;2-R |9 -- missing cx lookup -- |1 A Masaoka |p 2485 - |2 Crossref |u Masaoka A, Monden Y, Nakahara K et al (1981) Follow-up study of thymomas with special reference to their clinical stages. Cancer 48:2485–2492 |t Cancer |v 48 |y 1981 |
| 999 | C | 5 | |a 10.1016/1010-7940(94)90155-4 |9 -- missing cx lookup -- |1 A Masaoka |p 251 - |2 Crossref |u Masaoka A, Yamakawa Y, Niwa H et al (1994) Thymectomy and malignancy. Eur J Cardiothorac Surg 8:251–253 |t Eur J Cardiothorac Surg |v 8 |y 1994 |
| 999 | C | 5 | |a 10.1007/978-3-642-60157-6 |1 J Rosai |y 1999 |2 Crossref |u Rosai J (1999) Histological typing of tumours of the thymus. Springer, New York |9 -- missing cx lookup -- |
| 999 | C | 5 | |a 10.1007/s00595-005-3047-y |9 -- missing cx lookup -- |1 P Strobel |p 805 - |2 Crossref |u Strobel P, Marx A, Zettl A et al (2005) Thymoma and thymic carcinoma: an update of the WHO Classification 2004. Surg Today 35:805–811 |t Surg Today |v 35 |y 2005 |
| 999 | C | 5 | |a 10.1016/S0046-8177(78)80131-2 |9 -- missing cx lookup -- |1 GD Levine |p 495 - |2 Crossref |u Levine GD, Rosai J (1978) Thymic hyperplasia and neoplasia: a review of current concepts. Hum Pathol 9:495–515 |t Hum Pathol |v 9 |y 1978 |
| 999 | C | 5 | |a 10.1002/cncr.23492 |9 -- missing cx lookup -- |1 AM Marchevsky |p 2780 - |2 Crossref |u Marchevsky AM, Gupta R, Mckenna RJ et al (2008) Evidence-based pathology and the pathologic evaluation of thymomas: the World Health Organization classification can be simplified into only 3 categories other than thymic carcinoma. Cancer 112:2780–2788 |t Cancer |v 112 |y 2008 |
| 999 | C | 5 | |a 10.3109/07357900802563002 |9 -- missing cx lookup -- |1 KL Wu |p 1008 - |2 Crossref |u Wu KL, Mao JF, Chen GY et al (2009) Prognostic predictors and long-term outcome of postoperative irradiation in thymoma: a study of 241 patients. Cancer Invest 27:1008–1015 |t Cancer Invest |v 27 |y 2009 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2011.03.010 |9 -- missing cx lookup -- |1 S Patel |p 1797 - |2 Crossref |u Patel S, Macdonald OK, Nagda S et al (2012) Evaluation of the role of radiation therapy in the management of malignant thymoma. Int J Radiat Oncol Biol Phys 82:1797–1801 |t Int J Radiat Oncol Biol Phys |v 82 |y 2012 |
| 999 | C | 5 | |a 10.1097/COC.0b013e318042d566 |9 -- missing cx lookup -- |1 Y Kundel |p 389 - |2 Crossref |u Kundel Y, Yellin A, Popovtzer A et al (2007) Adjuvant radiotherapy for thymic epithelial tumor: treatment results and prognostic factors. Am J Clin Oncol 30:389–394 |t Am J Clin Oncol |v 30 |y 2007 |
| 999 | C | 5 | |a 10.1097/JTO.0b013e31821f9662 |9 -- missing cx lookup -- |1 JH Chang |p 1282 - |2 Crossref |u Chang JH, Kim HJ, Wu HG et al (2011) Postoperative radiotherapy for completely resected stage II or III thymoma. J Thorac Oncol 6:1282–1286 |t J Thorac Oncol |v 6 |y 2011 |
| 999 | C | 5 | |a 10.1097/JTO.0b013e3182745f73 |9 -- missing cx lookup -- |1 T Harnath |p 1867 - |2 Crossref |u Harnath T, Marx A, Strobel P et al (2012) Thymoma—a clinico-pathological long-term study with emphasis on histology and adjuvant radiotherapy dose. J Thorac Oncol 7:1867–1871 |t J Thorac Oncol |v 7 |y 2012 |
| 999 | C | 5 | |a 10.1002/cncr.10373 |9 -- missing cx lookup -- |1 K Ogawa |p 1405 - |2 Crossref |u Ogawa K, Uno T, Toita T et al (2002) Postoperative radiotherapy for patients with completely resected thymoma: a multi-institutional, retrospective review of 103 patients. Cancer 94:1405–1413 |t Cancer |v 94 |y 2002 |
| 999 | C | 5 | |a 10.1200/JCO.2004.10.113 |9 -- missing cx lookup -- |1 P Strobel |p 1501 - |2 Crossref |u Strobel P, Bauer A, Puppe B et al (2004) Tumor recurrence and survival in patients treated for thymomas and thymic squamous cell carcinomas: a retrospective analysis. J Clin Oncol 22:1501–1509 |t J Clin Oncol |v 22 |y 2004 |
| 999 | C | 5 | |1 V Vassiliou |y 2009 |2 Crossref |u Vassiliou V, Tsamandas A, Katodritis N et al (2009) The role of postoperative radiotherapy in the management of patients with thymic tumors—a retrospective study. In Vivo 23:843–852 |
| 999 | C | 5 | |a 10.1016/S0003-4975(03)00819-1 |9 -- missing cx lookup -- |1 S Singhal |p 1635 - |2 Crossref |u Singhal S, Shrager JB, Rosenthal DI et al (2003) Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg 76:1635–1641 (discussion 1641–1632) |t Ann Thorac Surg |v 76 |y 2003 |
| 999 | C | 5 | |a 10.1002/cncr.25851 |9 -- missing cx lookup -- |1 AT Berman |p 3502 - |2 Crossref |u Berman AT, Litzky L, Livolsi V et al (2011) Adjuvant radiotherapy for completely resected stage 2 thymoma. Cancer 117:3502–3508 |t Cancer |v 117 |y 2011 |
| 999 | C | 5 | |a 10.1016/S0003-4975(02)03828-6 |9 -- missing cx lookup -- |1 AA Mangi |p 1033 - |2 Crossref |u Mangi AA, Wright CD, Allan JS et al (2002) Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg 74:1033–1037 |t Ann Thorac Surg |v 74 |y 2002 |
| 999 | C | 5 | |a 10.1186/1748-717X-8-199 |9 -- missing cx lookup -- |1 C Fan |p 199 - |2 Crossref |u Fan C, Feng Q, Chen Y et al (2013) Postoperative radiotherapy for completely resected Masaoka stage III thymoma: a retrospective study of 65 cases from a single institution. Radiat Oncol 8:199 |t Radiat Oncol |v 8 |y 2013 |
| 999 | C | 5 | |a 10.1016/j.athoracsur.2012.03.004 |9 -- missing cx lookup -- |1 B Weksler |p 1822 - |2 Crossref |u Weksler B, Shende M, Nason KS et al (2012) The role of adjuvant radiation therapy for resected stage III thymoma: a population-based study. Ann Thorac Surg 93:1822–1828 (discussion 1828–1829) |t Ann Thorac Surg |v 93 |y 2012 |
| 999 | C | 5 | |a 10.1016/j.athoracsur.2004.12.051 |9 -- missing cx lookup -- |1 AA Mangi |p 1834 - |2 Crossref |u Mangi AA, Wain JC, Donahue DM et al (2005) Adjuvant radiation of stage III thymoma: is it necessary? Ann Thorac Surg 79:1834–1839 |t Ann Thorac Surg |v 79 |y 2005 |
| 999 | C | 5 | |a 10.1016/S0360-3016(99)00514-3 |9 -- missing cx lookup -- |1 M Myojin |p 927 - |2 Crossref |u Myojin M, Choi NC, Wright CD et al (2000) Stage III thymoma: pattern of failure after surgery and postoperative radiotherapy and its implication for future study. Int J Radiat Oncol Biol Phys 46:927–933 |t Int J Radiat Oncol Biol Phys |v 46 |y 2000 |
| 999 | C | 5 | |a 10.1056/NEJMoa040694 |9 -- missing cx lookup -- |1 R Sauer |p 1731 - |2 Crossref |u Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740 |t N Engl J Med |v 351 |y 2004 |
| 999 | C | 5 | |a 10.1007/s00066-013-0469-0 |9 -- missing cx lookup -- |1 FA Calvo |p 149 - |2 Crossref |u Calvo FA, Sole CV, Serrano J et al (2014) Preoperative chemoradiation with or without induction oxaliplatin plus 5-fluorouracil in locally advanced rectal cancer: long-term outcome analysis. Strahlenther Onkol 190:149–157 |t Strahlenther Onkol |v 190 |y 2014 |
| 999 | C | 5 | |a 10.1038/sj.bjc.6605731 |9 -- missing cx lookup -- |1 H Kunitoh |p 6 - |2 Crossref |u Kunitoh H, Tamura T, Shibata T et al (2010) A phase II trial of dose-dense chemotherapy, followed by surgical resection and/or thoracic radiotherapy, in locally advanced thymoma: report of a Japan Clinical Oncology Group trial (JCOG 9606). Br J Cancer 103:6–11 |t Br J Cancer |v 103 |y 2010 |
| 999 | C | 5 | |a 10.1016/j.jtcvs.2013.08.061 |9 -- missing cx lookup -- |1 RJ Korst |p 36 - |2 Crossref |u Korst RJ, Bezjak A, Blackmon S et al (2014) Neoadjuvant chemoradiotherapy for locally advanced thymic tumors: a phase II, multi-institutional clinical trial. J Thorac Cardiovasc Surg 147:36–44, 46 (e1) |t J Thorac Cardiovasc Surg |v 147 |y 2014 |
| 999 | C | 5 | |a 10.1016/S0360-3016(01)02656-6 |9 -- missing cx lookup -- |1 HC Hsu |p 801 - |2 Crossref |u Hsu HC, Huang EY, Wang CJ et al (2002) Postoperative radiotherapy in thymic carcinoma: treatment results and prognostic factors. Int J Radiat Oncol Biol Phys 52:801–805 |t Int J Radiat Oncol Biol Phys |v 52 |y 2002 |
| 999 | C | 5 | |a 10.1016/j.ijrobp.2003.11.021 |9 -- missing cx lookup -- |1 TY Eng |p 654 - |2 Crossref |u Eng TY, Fuller CD, Jagirdar J et al (2004) Thymic carcinoma: state of the art review. Int J Radiat Oncol Biol Phys 59:654–664 |t Int J Radiat Oncol Biol Phys |v 59 |y 2004 |
| 999 | C | 5 | |a 10.1016/j.hoc.2008.03.004 |9 -- missing cx lookup -- |1 LM Tormoehlen |p 509 - |2 Crossref |u Tormoehlen LM, Pascuzzi RM (2008) Thymoma, myasthenia gravis, and other paraneoplastic syndromes. Hematol Oncol Clin North Am 22:509–526 |t Hematol Oncol Clin North Am |v 22 |y 2008 |
| 999 | C | 5 | |a 10.1007/s00066-012-0297-7 |9 -- missing cx lookup -- |1 K Fakhrian |p 293 - |2 Crossref |u Fakhrian K, Oechsner M, Kampfer S et al (2013) Advanced techniques in neoadjuvant radiotherapy allow dose escalation without increased dose to the organs at risk: Planning study in esophageal carcinoma. Strahlenther Onkol 189:293–300 |t Strahlenther Onkol |v 189 |y 2013 |
| 999 | C | 5 | |a 10.1007/s00066-012-0159-3 |9 -- missing cx lookup -- |1 C Song |p 901 - |2 Crossref |u Song C, Pyo H, Kim J et al (2012) Superiority of conventional intensity-modulated radiotherapy over helical tomotherapy in locally advanced non-small cell lung cancer. A comparative plan analysis. Strahlenther Onkol 188:901–909 |t Strahlenther Onkol |v 188 |y 2012 |
| 999 | C | 5 | |a 10.1007/s00066-013-0501-4 |9 -- missing cx lookup -- |1 R Butof |p 263 - |2 Crossref |u Butof R, Kirchner K, Appold S et al (2014) Potential clinical predictors of outcome after postoperative radiotherapy of non-small cell lung cancer. Strahlenther Onkol 190:263–269 |t Strahlenther Onkol |v 190 |y 2014 |
| 999 | C | 5 | |a 10.1148/radiology.204.3.9280272 |9 -- missing cx lookup -- |1 D Latz |p 859 - |2 Crossref |u Latz D, Schraube P, Oppitz U et al (1997) Invasive thymoma: treatment with postoperative radiation therapy. Radiology 204:859–864 |t Radiology |v 204 |y 1997 |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|